Outlook Therapeutics- Warrants Profit Margin

As of the most recent data (March 2026), OTLKW shows a profit margin of -2459.38%. That compares with -61335367457.16% in the prior-year period — up 100.0% year over year. That is below the Healthcare sector average of 14.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OTLKW's profit margin is now -2459.38% (was -61335367457.16%) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Outlook Therapeutics- Warrants is outperforming or lagging.

The Healthcare sector average profit margin is about 14.34%. Outlook Therapeutics- Warrants is at -2459.38%, which is lower that average. That is roughly 17244.8% below the sector mean. Use the comparison chart on this page to see how OTLKW stacks up against individual peers as well.

That compares with -61335367457.16% in the prior-year period — up 100.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Outlook Therapeutics- Warrants with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Outlook Therapeutics- Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -2459.38%) with ownership activity and broader fundamentals.